Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-14 to 2024-02-15
Current total value of award: $285
Description: 4563711548!IBANDRONATE 3 MG/3 ML SYRINGE 3ML